본문으로 바로가기
현재 위치:
진료안내
진료과
의료진 소개
카카오 프린트

의료진 소개

김현중 의사

예약 안내

김현중 [ 심장혈관내과, 심장혈관센터, 관상동맥질환클리닉 ]

고혈압, 심부전, 판막질환, 관상동맥질환, 두근거림

고맙습니다 진료예약
외래진료 외래진료 특수클리닉 특수클리닉
진료일정 05
진료일정(날짜, 오전, 오후)
날짜
오전
오후

논문

논문
  • Kim TE, Kim HJ, Ki HK, Kim SH. The Impact of Metabolic Syndrome on Heart Failure in Young Korean Population: A Nationwide Study.  Metabolites. 2024 Sep;14(9):485. 
  • Kim HJ. Clinical significance of residual ischaemia in acute myocardial infarction complicated by cardiogenic shock undergoing venoarterial-extracorporeal membrane oxygenation.  European Heart Journal: Acute Cardiovascular Care. 2024 Jul;13(7):525-34. 
  • Kim HJ. Efficacy and safety of durable versus biodegradable polymer drug-eluting stents in patients with acute myocardial infarction complicated by cardiogenic shock.  Scientific Reports. 2024 Mar 15;14:6301. 
  • Kim BS, Kim HJ. Differential Prognostic Impact of IABP-SHOCK II Scores According to Treatment Strategy in Cardiogenic Shock Complicating Acute Coronary Syndrome: From the RESCUE Registry.  Medicina. 2024 Jan;60(1):183. 
  • Kim HJ. Association of Prophylactic Distal Perfusion Cannulation With Mortality in Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation.  American Journal of Cardiology. 2023 Nov 15;207:418-25. 
  • Kim HJ. Impact of Acute Myocardial Infarction Type on Prognosis in Female Patients With Cardiogenic Shock.  American Journal of Cardiology. 2023 Nov 1;206:116-24. 
  • Kim HJ. Predictors of in-hospital mortality after successful weaning of venoarterial extracorporeal membrane oxygenation in cardiogenic shock.  Scientific Reports. 2023 Oct 16;13:17529. 
  • Kim HJ. Culprit-Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial-Extracorporeal Membrane Oxygenation.  Journal of the American Heart Association. 2023 May 16;12(10):e029792. 
  • Kim BS, Kwon CH, Jang HS, Choi JH, Kim HJ, Kim SH. The association of cardiac troponin and cardiovascular events in patients with concomitant heart failure preserved ejection fraction and atrial fibrillation.  BMC Cardiovascular Disorders. 2023 May 24;23:273. 
  • Kim BS, Jang HS, Kim SH, Kwon CH, Jung SM, Park JJ, Kim HY, Kim HJ. Association of High-Sensitivity Troponin I with Cardiac and Cerebrovascular Events in Patient after Ischemic Stroke.  Cerebrovascular Diseases. 2023 Apr;52(2):153-9. 
  • Kim BS, Kim HJ, Kim TE, Kim SH. Different Impact of Metabolic Syndrome on the Risk of Incidence of the Peripheral Artery Disease and the Venous Thromboembolism: A Nationwide Longitudinal Cohort Study in South Korea.  Reviews in Cardiovascular Medicine. 2023 Apr;24(4):113. 
  • Kim H, Lee TH, Kim HJ, Yang HS, Lee KR, Hur M. Performance Evaluation of AFIAS ST2 and Ichroma ST2 Assays in Comparison with Presage ST2 Assay.  Reviews in Cardiovascular Medicine. 2023 Apr;24(4):100. 
  • Kim HJ. Non-culprit left main coronary artery disease in acute myocardial infarction complicated by cardiogenic shock.  PLoS One. 2023 Mar 30;18(3):e0276711. 
  • Kim HJ. Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice.  Journal of Korean Medical Science. 2023 Feb 6;38(5):e34. 
  • Kim HJ. Inodilators May Improve the In-Hospital Mortality of Patients with Cardiogenic Shock Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation.  Journal of Clinical Medicine. 2022 Sep;11(17):4958. 
  • Kim HJ, Kim BS. Prognostic Impact of Plasma Glucose on Patients With Cardiogenic Shock With or Without Diabetes Mellitus from the SMART RESCUE Trial.  American Journal of Cardiology. 2022 Jul 15;175:145-51. 
  • Kim HJ. Impact of the Obesity Paradox Between Sexes on In-Hospital Mortality in Cardiogenic Shock: A Retrospective Cohort Study.  Journal of the American Heart Association. 2022 Jun 7;11:e024143. 
  • Chang HS, Kim BS, Kim SH, Kim HJ, Kim TY, Kwon CH. Predictors and prognostic impact of post-operative atrial fibrillation in patients with hip fracture surgery.  World Journal of Clinical Cases. 2022 Apr 16;10(11):3379-88. 
  • Kim BS, Kim HJ. Clinical significance of lactate clearance in patients with cardiogenic shock: results from the RESCUE registry.  Journal of Intensive Care. 2021 Oct 18;9:63. 
  • Kim HJ, Kim BS. Association between polyvascular disease and clinical outcomes in patients with cardiogenic shock: Results from the RESCUE registry.  International Journal of Cardiology. 2021 Sep 15;339:70-4. 
  • Kim HJ. Comparison of in-hospital outcomes of patients with vs. without ischaemic cardiomyopathy undergoing veno-arterial-extracorporeal membrane oxygenation.  ESC Heart Failure. 2021 Aug;8(4):3308-15. 
  • Kim HJ, Kim BS. Clinical Characteristics and Predictors of In-Hospital Mortality in Patients With Cardiogenic Shock: Results From the RESCUE Registry.  Circulation. Heart Failure. 2021 Jun;14(6):e008141. 
  • Kim HJ. Differential Prognostic Implications of Vasoactive Inotropic Score for Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock According to Use of Mechanical Circulatory Support.  Critical Care Medicine. 2021 May;49(5):770-80. 
  • Kim JW, Lee KR, Yun Y, Kim HJ, Kim H. Absolute Change in High-Sensitivity Cardiac Troponin I at Three Hours After Presentation is Useful for Diagnosing Acute Myocardial Infarction in the Emergency Department.  Annals of Laboratory Medicine. 2020 Nov;40(6):474-80. 
  • Kim HJ, Kim BS. Clinical Significance of Low-Flow Time in Patients Undergoing Extracorporeal Cardiopulmonary Resuscitation: Results from the RESCUE Registry.  Journal of Clinical Medicine. 2020 Nov;9(11):3588. 
  • Kim BS, Kwon CH, Chang HS, Kim HJ, Hwang HK, Jung SM, Kim SH. Usefulness of High-Sensitivity Troponin I to Predict Outcome in Patients With Newly Detected Atrial Fibrillation.  American Journal of Cardiology. 2020 Mar 1;125(5):744-50. 
  • Kim BS, Eom SY, Kim SH, Hwang HK, Park JS, Kim W, Lee JW, Rha SW, Kim GY, Lim SW, Lee SH, Chae JK, Woo SI, Bae JW, Kim HJ. Effect of Pre-Procedural Beta-Blocker on Clinical Outcome after Percutaneous Coronary Intervention in Acute Coronary Syndrome.  International Heart Journal. 2019 Nov2019 Nov;60(6):1284-1292. 
  • Kwon CH, Kim H, Kim SH, Kim BS, Kim HJ, Kim DK, Han SW, Ryu KH, Sung JD. The Impact of Metabolic Syndrome on the Incidence of Atrial Fibrillation: A Nationwide Longitudinal Cohort Study in South Korea.  Journal of Clinical Medicine. 2019 Aug2019 Aug;8(8):1095. 
  • Kim SH, Kim HJ. The limited prognostic role of echocardiograms in short-term follow-up after acute decompensated heart failure: An analysis of the Korean Heart Failure (KorHF) Registry.  PLoS One. 2017 Dec 19;12:e0188938. 
  • Park SJ, Kim BS, Kim SH, Kim HJ, Hwang HG, Jung SM, Bae BJ, Kwon CH. Diagnostic value of the corrected QT difference between leads V1 and V6 in patients with acute pulmonary thromboembolism.  Medicine. 2017 Oct;96(43):e8430. 
  • KIM H, Lee J, Song W, Shin J, Oh D, Harrison K, Jakkula M, Chiu Wong S, Hong MK. Feasibility and safety of regional myocardial hypothermia during myocardial ischemia and infarction in pigs.  Coron Artery Dis. 2005;16:125-9. 
  • Song W, Lee J, Kim H, Shin J, Oh D, Tio F, Wong SC, Hong MK. A new percutaneous porcine coronary model of chronic total occlusion.  J Invasive Cardiol. 2005;17:452-4. 
  • Song W, Shin J, Lee J, Kim H, Oh D, Edelberg JM, Wong SC, Szeto H, Hong MK. A potent opiate agonist protects against myocardial stunning during myocardial ischemia and reperfusion in rats.  Coron Artery Dis. 2005;16:407-10. 
  • KIM H, Lee J, Song W, Shin J, Oh D, Harrison K, Jakkula M, Chiu Wong S, Hong MK. Feasibility and safety of regional myocardial hypothermia during myocardial ischemia and infarction in pigs.  Coron Artery Dis. 2005. 
  • 김현중, 유규형. 급성 대상부전 심부전 환자의 치료.  순환기. 2005. 
  • KIM HJ, Jang SY, Park JI, Byun J, Kim DI, Do YS, Kim JM, Kim S, Kim BM, Kim WB, Kim DK. Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease.  Exp Mol Med. 2004;36: 336-44. 
  • KIM HJ, Ahn SJ, Park SW, Cho BR, Sung J, Hong SH, Park PW, Hong KP. Cardiopulmonary exercise testing before and one year after mitral valve repair for severe mitral regurgitation.  Am J Cardiol. 2004;93:1187-9. 
  • KIM HJ, Jang SY, Park JI, Byun J, Kim DI, Do YS, Kim JM, Kim S, Kim BM, Kim WB, Kim DK. Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease.  Exp Mol Med. 2004. 
  • 김현중, 장형석, 이영삼, 김경리, 변종해, 김정아, 김정민, 전은석, 김덕경. 전기자극에 의한 유전자 전달 골격근을 이용한 간편하고 정량적인 혈관신생 유전자 평가 시스템 개발.  순환기. 2003. 
  • 김현중, 박승우, 조병렬, 홍선희, 박표원, 홍경표. The Role of Cardiopulmonary Exercise Test in Mitral and Aortic Regurgitation: It Can Predict Post-Operative Results.  The Korean Journal of Internal Medicine. 2003. 
  • 김현중, 장신이, 김종묵, 김선영, 김병문, 김원배, 김덕경. Vascular endothelial growth factor (VEGF)-induced angiogenic gene therapy in a patient with critical limb ischemia.  대한내과학회지. 2003.